Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance
| Antimicrobial Resistance. Global Report on Surveillance [[electronic resource] ] : Global Report on Surveillance |
| Autore | Organization World Health |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2014 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 616 |
| Soggetto topico |
Drug resistance -- Periodicals
Drug resistance in microorganisms Drug resistance Anti-infective agents - Classification Drug resistance in microorganisms - Effect of drugs on Risk management Risk Risk Management Information Science Drug Resistance Microbiological Phenomena Epidemiologic Measurements Therapeutic Uses Probability Pharmacologic Actions Pharmacological Phenomena Public Health Organization and Administration Statistics as Topic Health Services Administration Environment and Public Health Chemical Actions and Uses Physiological Phenomena Health Care Evaluation Mechanisms Health Care Epidemiologic Methods Drug Therapy Quality of Health Care Investigative Techniques Diagnostic Techniques and Procedures Health Care Quality, Access, and Evaluation Anti-Infective Agents Classification Risk Assessment Drug Resistance, Microbial Biology Health & Biological Sciences Microbiology & Immunology |
| Soggetto genere / forma |
Publication Formats
Technical Report |
| ISBN | 92-4-069266-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Contents; Foreword; Summary; Acknowledgements; Abbreviations; Introduction; SECTION 01 Resistance to antibacterial drugs; 1.1 Background; 1.1.1 Limitations; 1.2 Regional surveillance of antibacterial resistance; 1.2.1 WHO African Region; 1.2.2 WHO Region of the Americas; 1.2.3 WHO Eastern Mediterranean Region; 1.2.4 WHO European Region; 1.2.5 WHO South-East Asia Region; 1.2.6 WHO Western Pacific Region; 1.3 References; SECTION 02 Resistance to antibacterial drugs in selected bacteria of international concern; 2.1 Availability of national resistance data; 2.1.1 Key messages
2.2 Resistance data on specific pathogens2.2.1 Escherichia coli - resistance to third-generation cephalosporins and to fluoroquinolones; 2.2.2 Klebsiella pneumoniae - resistance to third-generation cephalosporins and to carbapenems; 2.2.3 Staphylococcus aureus - resistance to methicillin; 2.2.4 Streptococcus pneumoniae - resistance (non-susceptibility) to penicillin; 2.2.5 Nontyphoidal Salmonella - resistance to fluoroquinolones; 2.2.6 Shigella species - resistance to fluoroquinolones; 2.2.7 Neisseria gonorrhoeae - decreased susceptibility to third-generation cephalosporins; 2.3 References SECTION 03 The health and economic burden due to antibacterial resistance3.1 Methods; 3.2 Findings; 3.2.1 Health burden; 3.2.2 Economic burden; 3.3 Knowledge gaps; 3.4 Key messages; 3.5 References; SECTION 04 Surveillance of antimicrobial drug resistance in disease-specific programmes; 4.1 Tuberculosis; 4.1.1 Evolution of drug resistance in tuberculosis; 4.1.2 Surveillance of drug-resistant tuberculosis; 4.1.3 Global public health response to drug-resistant tuberculosis; 4.1.4 Notification of MDR-TB cases and enrolment on treatment 4.1.5 Public health implications: treatment outcomes for multidrug-resistant and extensively drug-resistant tuberculosis4.1.6 Key messages; 4.2 Malaria; 4.2.1 Evolution of antimalarial drug resistance; 4.2.2 Surveillance of antimalarial therapeutic efficacy and resistance; 4.2.3 Global public health implications of antimalarial drug resistance; 4.2.4 Key messages; 4.3 HIV; 4.3.1 Surveillance of anti-HIV drug resistance; 4.3.2 Global public health implications of anti-HIV drug resistance; 4.3.3 Key messages; 4.4 Influenza; 4.4.1 Evolution of resistance in influenza viruses 4.4.2 Anti-influenza drug resistance4.4.3 Surveillance of anti-influenza drug resistance; 4.4.4 Public health implications of anti-influenza drug resistance; 4.4.5 Key messages; 4.5 References; SECTION 05 Surveillance of antimicrobial resistance in other areas; 5.1 Antibacterial resistance in food-producing animals and the food chain; 5.1.1 Ongoing surveillance of antimicrobial resistance in food-producing animals and food; 5.1.2 Integrated surveillance of antimicrobial resistance in foodborne bacteria; 5.1.3 Antimicrobials of particular importance in human and veterinary medicine 5.1.4 Implications for human health from zoonotic transmission of resistant bacteria and genetic material |
| Record Nr. | UNINA-9910825162403321 |
Organization World Health
|
||
| Geneva, : World Health Organization, 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
| Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
| Autore | Kazmierski Wieslaw M |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (470 p.) |
| Disciplina | 615/.7924 |
| Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
| Record Nr. | UNINA-9910139613803321 |
|
Kazmierski Wieslaw M
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials
| Antiviral Drugs [[electronic resource] ] : From Basic Discovery Through Clinical Trials |
| Autore | Kazmierski Wieslaw M |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (470 p.) |
| Disciplina | 615/.7924 |
| Soggetto topico |
Antiviral Agents -- therapeutic use
Antiviral agents Clinical Trials as Topic Drug Discovery Drug Evaluation Epidemiologic Studies Chemistry, Pharmaceutical Evaluation Studies as Topic Investigative Techniques Anti-Infective Agents Epidemiologic Methods Pharmacology Therapeutic Uses Health Care Evaluation Mechanisms Chemistry Biological Science Disciplines Natural Science Disciplines Quality of Health Care Public Health Pharmacologic Actions Environment and Public Health Health Care Quality, Access, and Evaluation Chemical Actions and Uses Health Care Antiviral Agents Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-20363-4
9786613203632 0-470-92935-9 0-470-92934-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
ANTIVIRAL DRUGS; CONTENTS; CONTRIBUTORS; PREFACE; PART I HUMAN IMMUNODEFICIENCY VIRUS; 1 Discovery and Development of Atazanavir; 2 Discovery and Development of PL-100, A Novel HIV-1 Protease Inhibitor; 3 Darunavir (Prezista, TMC114): From Bench to Clinic, Improving Treatment Options for HIV-Infected Patients; 4 Discovery and Development of Tipranavir; 5 TMC278 (Rilpivirine): A Next-Generation NNRTI in Phase III Clinical Development for Treatment-Naive Patients; 6 Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV-Infected Patients
7 Discovery and Development of Tenofovir Disoproxil Fumarate8 Discovery and Development of Apricitabine; 9 Discovery and Development of Maraviroc and PF-232798: CCR5 Antagonists for the Treatment of HIV-1 Infection; 10 Discovery of the CCR5 Antagonist Vicriviroc (Sch 417690/Sch-D) for the Treatment of HIV-1 Infection; 11 Discovery and Development of HIV-1 Entry Inhibitors That Target gp120; 12 Discovery of MK-0536: A Potential Second-Generation HIV-1 Integrase Strand Transfer Inhibitor with a High Genetic Barrier to Mutation; 13 Discovery and Development of HIV Integrase Inhibitor Raltegravir 14 Elvitegravir: A Novel Monoketo Acid HIV-1 Integrase Strand Transfer InhibitorPART II HEPATITIS C VIRUS; 15 Discovery and Development of Telaprevir; 16 Discovery and Development of BILN 2061 and Follow-up BI 201335; 17 Intervention of Hepatitis C Replication Through NS3-4A, the Protease Inhibitor Boceprevir; 18 Discovery and Development of the HCV NS3/4A Protease Inhibitor Danoprevir (ITMN-191/RG7227); 19 Discovery and Development of the HCV Protease Inhibitor TMC435; 20 Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection 21 Discovery and Development of PSI-6130/RG712822 Discovery of Cyclophilin Inhibitor NIM811 as a Novel Therapeutic Agent for HCV; 23 HCV Viral Entry Inhibitors; PART III RESPIRATORY SYNCYTIAL VIRUS INHIBITORS; 24 Discovery of the RSV Inhibitor TMC353121; 25 Discovery and Development of Orally Active RSV Fusion Inhibitors; 26 Discovery and Development of RSV604; PART IV INFLUENZA, HEPATITIS B, AND CYTOMEGALOVIRUS INHIBITORS; 27 Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza; 28 Discovery and Development of Entecavir 29 Benzimidazole Ribonucleosides: Novel Drug Candidates for the Prevention and Treatment of Cytomegalovirus DiseasesINDEX; Color Plate |
| Record Nr. | UNINA-9910808713803321 |
|
Kazmierski Wieslaw M
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Asthma [[electronic resource] ] : Modern Therapeutic Targets
| Asthma [[electronic resource] ] : Modern Therapeutic Targets |
| Autore | Polosa Riccardo |
| Pubbl/distr/stampa | Oxford, : Atlas Medical Publishing Ltd, 2007 |
| Descrizione fisica | 1 online resource (205 p.) |
| Disciplina | 616.2/38061 |
| Altri autori (Persone) | HolgateS. T |
| Collana | Therapeutic Strategies |
| Soggetto topico |
Anti-inflammatory agents
Asthma -- Treatment Asthma Respiratory Hypersensitivity Lung Diseases, Obstructive Respiratory System Agents Bronchial Diseases Respiratory Tract Diseases Therapeutic Uses Lung Diseases Hypersensitivity, Immediate Diseases Hypersensitivity Pharmacologic Actions Chemical Actions and Uses Immune System Diseases Anti-Asthmatic Agents |
| ISBN |
1-280-75122-3
9786610751228 1-84692-564-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Contents; Editors and Contributors; Preface; Section I: Autocoids and their receptors in airway diseases; Section II: Enzyme inhibitors; Section III: Sensory nerves and sensory neuropeptides; Section IV: Receptors in immunology; Abbreviations; Index |
| Record Nr. | UNISA-996339117803316 |
|
Polosa Riccardo
|
||
| Oxford, : Atlas Medical Publishing Ltd, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
B vitamins and berries and age-related neurodegenerative disorders
| B vitamins and berries and age-related neurodegenerative disorders |
| Pubbl/distr/stampa | [Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2006 |
| Descrizione fisica | 1 online resource |
| Collana |
Evidence Reports/Technology Assessments
AHRQ publication |
| Soggetto topico |
Food
Vitamins Plant Components, Aerial Nervous System Diseases Food and Beverages Diseases Micronutrients Plant Structures Anatomy Technology, Industry, and Agriculture Growth Substances Physiological Effects of Drugs Pharmacologic Actions Chemical Actions and Uses Vitamin B Complex Fruit Neurodegenerative Diseases Psychiatry Health & Biological Sciences Psychiatric Disorders, Individual |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910698279803321 |
| [Place of publication not identified], : U S Dept of Health and Human Services Agency for Healthcare Research and Quality, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Carcinogenic and anticarcinogenic factors in food : symposium
| Carcinogenic and anticarcinogenic factors in food : symposium |
| Pubbl/distr/stampa | [Place of publication not identified], : Wiley VCH, 2000 |
| Descrizione fisica | 1 online resource (539 pages) |
| Disciplina | 616.99/40654 |
| Collana | Forschungsberichte (DFG) |
| Soggetto topico |
Carcinogens - Toxicology
Food - Nutritional aspects Cancer Risk Factors Carcinogens Anticarcinogenic Agents Neoplasms Diet Food Analysis Risk Causality Noxae Protective Agents Diseases Food Technology Nutritional Physiological Phenomena Investigative Techniques Antineoplastic Agents Probability Food Industry Toxic Actions Analytical, Diagnostic and Therapeutic Techniques and Equipment Physiological Phenomena Specialty Uses of Chemicals Epidemiologic Factors Therapeutic Uses Physiological Effects of Drugs Chemical Actions and Uses Statistics as Topic Pharmacologic Actions Phenomena and Processes Quality of Health Care Industry Public Health Epidemiologic Methods Chemicals and Drugs Technology, Industry, and Agriculture Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Evaluation Mechanisms Health Care Technology, Industry, Agriculture Oncology Medicine Health & Biological Sciences |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-55818-0
9786610558186 3-527-60624-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910143969803321 |
| [Place of publication not identified], : Wiley VCH, 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Carcinogenic and anticarcinogenic factors in food : symposium
| Carcinogenic and anticarcinogenic factors in food : symposium |
| Pubbl/distr/stampa | [Place of publication not identified], : Wiley VCH, 2000 |
| Descrizione fisica | 1 online resource (539 pages) |
| Disciplina | 616.99/40654 |
| Collana | Forschungsberichte (DFG) |
| Soggetto topico |
Carcinogens - Toxicology
Food - Nutritional aspects Cancer Risk Factors Carcinogens Anticarcinogenic Agents Neoplasms Diet Food Analysis Risk Causality Noxae Protective Agents Diseases Food Technology Nutritional Physiological Phenomena Investigative Techniques Antineoplastic Agents Probability Food Industry Toxic Actions Analytical, Diagnostic and Therapeutic Techniques and Equipment Physiological Phenomena Specialty Uses of Chemicals Epidemiologic Factors Therapeutic Uses Physiological Effects of Drugs Chemical Actions and Uses Statistics as Topic Pharmacologic Actions Phenomena and Processes Quality of Health Care Industry Public Health Epidemiologic Methods Chemicals and Drugs Technology, Industry, and Agriculture Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Evaluation Mechanisms Health Care Technology, Industry, Agriculture Oncology Medicine Health & Biological Sciences |
| ISBN |
1-280-55818-0
9786610558186 3-527-60624-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910830883603321 |
| [Place of publication not identified], : Wiley VCH, 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Carcinogenic and anticarcinogenic factors in food : symposium
| Carcinogenic and anticarcinogenic factors in food : symposium |
| Pubbl/distr/stampa | [Place of publication not identified], : Wiley VCH, 2000 |
| Descrizione fisica | 1 online resource (539 pages) |
| Disciplina | 616.99/40654 |
| Collana | Forschungsberichte (DFG) |
| Soggetto topico |
Carcinogens - Toxicology
Food - Nutritional aspects Cancer Risk Factors Carcinogens Anticarcinogenic Agents Neoplasms Diet Food Analysis Risk Causality Noxae Protective Agents Diseases Food Technology Nutritional Physiological Phenomena Investigative Techniques Antineoplastic Agents Probability Food Industry Toxic Actions Analytical, Diagnostic and Therapeutic Techniques and Equipment Physiological Phenomena Specialty Uses of Chemicals Epidemiologic Factors Therapeutic Uses Physiological Effects of Drugs Chemical Actions and Uses Statistics as Topic Pharmacologic Actions Phenomena and Processes Quality of Health Care Industry Public Health Epidemiologic Methods Chemicals and Drugs Technology, Industry, and Agriculture Environment and Public Health Health Care Quality, Access, and Evaluation Health Care Evaluation Mechanisms Health Care Technology, Industry, Agriculture Oncology Medicine Health & Biological Sciences |
| ISBN |
1-280-55818-0
9786610558186 3-527-60624-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910841388803321 |
| [Place of publication not identified], : Wiley VCH, 2000 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Gendered Moods : Psychotropics and Society
| Gendered Moods : Psychotropics and Society |
| Autore | Ettorre Elizabeth M. |
| Pubbl/distr/stampa | New York, : Routledge, 1995 |
| Descrizione fisica | 1 online resource (188 p.) |
| Disciplina |
306.461
615/.788 |
| Soggetto topico |
Drugs
Psychotropic drugs Women Medicine Pharmacy Social Science Psychotropic drugs - Drug use Psychotropic Drugs Sex Factors Affect Persons Emotions Epidemiologic Factors Central Nervous System Agents Named Groups Quality of Health Care Public Health Therapeutic Uses Behavior and Behavior Mechanisms Health Care Quality, Access, and Evaluation Environment and Public Health Psychiatry and Psychology Pharmacologic Actions Chemical Actions and Uses Delivery of Health Care Chemicals and Drugs Pharmacy, Therapeutics, & Pharmacology Health & Biological Sciences |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-32130-X
0-585-45201-6 9786610321308 0-203-41866-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Book Cover; Title; Contents; List of tables; Acknowledgements; Introduction: psychotropics and women; setting the scene; New challenges: the medical and sociological discourses; Social scientific perspectives: the 'users' and the 'providers'; Making gender visible: seeing 'layers' in the social construction of psychotropic drug use; Advertising as a representation of gendered moods; Analysing long-term use: users' narratives; Gendered moods and the lay culture; Dependency and the health care system; Bibliography; Name index; Subject index; |
| Record Nr. | UNINA-9910172230303321 |
|
Ettorre Elizabeth M.
|
||
| New York, : Routledge, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Gendered Moods : Psychotropics and Society
| Gendered Moods : Psychotropics and Society |
| Autore | Ettorre Elizabeth M. |
| Pubbl/distr/stampa | New York, : Routledge, 1995 |
| Descrizione fisica | 1 online resource (188 p.) |
| Disciplina |
306.461
615/.788 |
| Soggetto topico |
Drugs
Psychotropic drugs Women Medicine Pharmacy Social Science Psychotropic drugs - Drug use Psychotropic Drugs Sex Factors Affect Persons Emotions Epidemiologic Factors Central Nervous System Agents Named Groups Quality of Health Care Public Health Therapeutic Uses Behavior and Behavior Mechanisms Health Care Quality, Access, and Evaluation Environment and Public Health Psychiatry and Psychology Pharmacologic Actions Chemical Actions and Uses Delivery of Health Care Chemicals and Drugs Pharmacy, Therapeutics, & Pharmacology Health & Biological Sciences |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-32130-X
0-585-45201-6 9786610321308 0-203-41866-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Book Cover; Title; Contents; List of tables; Acknowledgements; Introduction: psychotropics and women; setting the scene; New challenges: the medical and sociological discourses; Social scientific perspectives: the 'users' and the 'providers'; Making gender visible: seeing 'layers' in the social construction of psychotropic drug use; Advertising as a representation of gendered moods; Analysing long-term use: users' narratives; Gendered moods and the lay culture; Dependency and the health care system; Bibliography; Name index; Subject index; |
| Record Nr. | UNISA-996199872603316 |
|
Ettorre Elizabeth M.
|
||
| New York, : Routledge, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
